YATHARTH HOSPITAL has announced its results for the year ended March 2024. Let us have a look at the detailed performance review of the company during FY23-24.
No. of Mths Year Ending | 12 Mar-23* | 12 Mar-24* | % Change | |
---|---|---|---|---|
Net Sales | Rs m | 5,203 | 4,198 | -19.3% |
Other income | Rs m | 28 | 136 | 382.9% |
Total Revenues | Rs m | 5,231 | 4,333 | -17.2% |
Gross profit | Rs m | 1,352 | 1,189 | -12.0% |
Depreciation | Rs m | 275 | 134 | -51.1% |
Interest | Rs m | 228 | 59 | -74.1% |
Profit before tax | Rs m | 877 | 1,131 | 29.0% |
Tax | Rs m | 219 | 291 | 32.9% |
Profit after tax | Rs m | 658 | 840 | 27.7% |
Gross profit margin | % | 26.0 | 28.3 | |
Effective tax rate | % | 25.0 | 25.7 | |
Net profit margin | % | 12.6 | 20.0 |
Must See: These Segments are Witnessing Incredible Growth with Modi's Push
No. of Mths Year Ending | 12 Mar-23* | 12 Mar-24* | % Change | |
---|---|---|---|---|
Networth | Rs m | 1,830 | 8,370 | 357.5 |
Current Liabilities | Rs m | 995 | 336 | -66.3 |
Long-term Debt | Rs m | 2,006 | 20 | -99.0 |
Total Liabilities | Rs m | 4,777 | 8,784 | 83.9 |
Current assets | Rs m | 1,763 | 6,636 | 276.5 |
Fixed Assets | Rs m | 3,014 | 2,148 | -28.7 |
Total Assets | Rs m | 4,777 | 8,784 | 83.9 |
Particulars | No. of months | 12 | 12 | % Change |
---|---|---|---|---|
Year Ending | Mar-23 | Mar-24 | ||
Cash Flow from Operating Activities | Rs m | 638 | 160 | -75.0% |
Cash Flow from Investing Activities | Rs m | -203 | -1,675 | - |
Cash Flow from Financing Activities | Rs m | -177 | 2,406 | - |
Net Cash Flow | Rs m | 257 | 891 | 246.2% |
No. of Mths Year Ending | 12 Mar-23* | 12 Mar-24* | |
---|---|---|---|
Sales per share (Unadj.) | Rs | 79.4 | 48.9 |
TTM Earnings per share | Rs | 10.0 | 9.8 |
Diluted earnings per share | Rs | 7.7 | 9.8 |
Price to Cash Flow | x | 0.0 | 35.6 |
TTM P/E ratio | x | 0.0 | 38.2 |
Price / Book Value ratio | x | 0.0 | 4.1 |
Market Cap | Rs m | 0 | 34,679 |
Dividends per share (Unadj.) | Rs | 0.0 | 0.0 |
Current Ratio: The company's current ratio improved and stood at 19.8x during FY24, from 1.8x during FY23. The current ratio measures the company's ability to pay short-term and long-term obligations.
Interest Coverage Ratio: The company's interest coverage ratio improved and stood at 20.2x during FY24, from 4.8x during FY23. The interest coverage ratio of a company states how easily a company can pay its interest expense on outstanding debt. A higher ratio is preferable.
Return on Equity (ROE): The ROE for the company declined and down at 10.0% during FY24, from 35.9% during FY24. The ROE measures the ability of a firm to generate profits from its shareholders capital in the company.
Return on Capital Employed (ROCE): The ROCE for the company declined and down at 14.2% during FY24, from 28.8% during FY23. The ROCE measures the ability of a firm to generate profits from its total capital (shareholder capital plus debt capital) employed in the company.
Return on Assets (ROA): The ROA of the company declined and down at 10.2% during FY24, from 18.5% during FY23. The ROA measures how efficiently the company uses its assets to generate earnings.
No. of Mths Year Ending | 12 Mar-23* | 12 Mar-24* | |
---|---|---|---|
Current ratio | x | 1.8 | 19.8 |
Debtors’ Days | Days | 76 | 125 |
Interest coverage | x | 4.8 | 20.2 |
Debt to equity ratio | x | 1.1 | 0.0 |
Return on assets | % | 18.5 | 10.2 |
Return on equity | % | 35.9 | 10.0 |
Return on capital employed | % | 28.8 | 14.2 |
To see how YATHARTH HOSPITAL has performed over the last 5 years, please visit here.
Over the last one year, YATHARTH HOSPITAL share price has moved up from Rs 387.2 to Rs 560.0, registering a gain of Rs 172.8 or around 44.6%.
Meanwhile, the S&P BSE HEALTHCARE Index is trading at Rs 44,308.1 (down 0.1%). Over the last one year it has moved up from 28,682.7 to 44,308.1, a gain of 15,625 points (up 54.5%).
Overall, the S&P BSE SENSEX is up 23.0% over the year.
(To know more, check out historical annual results for YATHARTH HOSPITAL and quarterly results for YATHARTH HOSPITAL)
YATHARTH HOSPITAL currently trades at Rs 612.8 per share. You can check out the latest share price performance of YATHARTH HOSPITAL here...
The revenues of YATHARTH HOSPITAL stood at Rs 4,333 m in FY24, which was down -17.2% compared to Rs 5,231 m reported in FY23.
YATHARTH HOSPITAL's revenue has grown from Rs 1,462 m in FY20 to Rs 4,333 m in FY24.
Over the past 5 years, the revenue of YATHARTH HOSPITAL has grown at a CAGR of 31.2%.
The net profit of YATHARTH HOSPITAL stood at Rs 840 m in FY24, which was up 27.7% compared to Rs 658 m reported in FY23.
This compares to a net profit of Rs 442 m in FY22 and a net profit of Rs 196 m in FY21.
Over the past 5 years, YATHARTH HOSPITAL net profit has grown at a CAGR of NaN%.
The cash flow statement is the financial statement that presents the cash inflows and outflows of a company during a given period of time.
This statement is one of the most useful tools for judging a company's liquidity position. The ratios and parameters in this statement helps test a company's financial health.
The cash flow statement of YATHARTH HOSPITAL reveals:
Here's the cash flow statement of YATHARTH HOSPITAL for the past 5 years.
(Rs m) | FY20 | FY21 | FY22 | FY23 | FY24 |
---|---|---|---|---|---|
From Operations | 392 | 437 | 599 | 638 | 160 |
From Investments | -433 | -212 | -522 | -203 | -1,675 |
From Financial Activity | 53 | -191 | -11 | -177 | 2,406 |
Net Cashflow | 13 | 34 | 67 | 257 | 891 |
Be it the company's profitability, operations effectiveness or utilization of funds, ratio analysis is an important tool which helps in making investment decisions.
The ratio/financial analysis of YATHARTH HOSPITAL reveals:
Here's the ratio/financial analysis of YATHARTH HOSPITAL for the past 5 years.
FY20 | FY21 | FY22 | FY23 | FY24 | |
---|---|---|---|---|---|
Operating Profit Margin (%) | 26.3 | 29.8 | 27.9 | 26.0 | 28.3 |
Net Profit Margin (%) | -1.4 | 8.6 | 11.0 | 12.6 | 20.0 |
Debt to Equity Ratio (x) | 2.9 | 2.3 | 1.8 | 1.1 | 0.0 |
Equitymaster requests your view! Post a comment on "YATHARTH HOSPITAL 2023-24 Annual Report Analysis". Click here!
Comments are moderated by Equitymaster, in accordance with the Terms of Use, and may not appear
on this article until they have been reviewed and deemed appropriate for posting.
In the meantime, you may want to share this article with your friends!